Treating Scalp Psoriasisdoi:10.1177/247553030006a00302Robert CarruthersRobert CarruthersMount SinaiRobert CarruthersPsoriasis Forum
The present invention relates to therapeutic agents for psoriasis of nails and scalp, including IL-17 receptor A (IL-17RA, or IL-17R) antigen binding proteins, such as monoclonal antibodies that bind to IL-17RA, and uses thereof Method.ニルラ,アジャイ...
PSORIASISALOPECIA areataPatients with psoriasis have itchy and scaly patches of skin on the body, commonly affecting the scalp, elbows, chest and/or knees. Up to 80% of people with psoriasis also have scalp psoriasis, and this can be difficult to treat.British Journal of Der...
The present invention relates to therapeutic agents for psoriasis of nails and scalp, including IL-17 receptor A (IL-17RA, or IL-17R) antigen binding proteins, such as monoclonal antibodies that bind to IL-17RA, and uses thereof Method.ニルラ,アジャイ...
Compositions useful for the treatment of hyperproliferative dermal diseases of the scalp. Specifically, topical gel and liquid compositions that include calcipotriol and nicotinamide in a polyethylene glycol-based carrier, for topical application to the scalp.EVEN-CHEN, ZEEV...
Compositions useful for the treatment of hyperproliferative dermal diseases of the scalp. Specifically, topical gel and liquid compositions that include calcipotriol and nicotinamide in a polyethylene glycol-based carrier, for topical application to the scalp.doi:US20130217655 A1Zeev Even-ChenUS...
Compositions useful for the treatment of hyperproliferative dermal diseases of the scalp. Specifically, topical gel and liquid compositions that include calcipotriol and nicotinamide in a polyethylene glycol-based carrier, for topical application to the scalp.ZEEV EVEN-CHEN...
The present invention relates to a therapeutic agent for nail and scalp psoriasis comprising an IL-17 Receptor A (IL-17RA or IL-17R) antigen binding proteins, such as monoclonal antibodies that bind IL-17RA, and method of using the same.Ajay Nirula...
The present invention relates to a therapeutic agent for nail and scalp psoriasis comprising an IL-17 Receptor A (IL-17RA or IL-17R) antigen binding proteins, such as monoclonal antibodies that bind IL-17RA, and method of using the same.NIRULA Ajay...
The present invention relates to a therapeutic agent for nail and scalp psoriasis comprising an IL-17 Receptor A (IL-17RA or IL-17R) antigen binding proteins, such as monoclonal antibodies that bind IL-17RA, and method of using the same.NIRULA, Ajay...